HOLLISTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the "Company”) today announced ...

Discover key takeaways from Oracle's earnings results, why the stock nears buy territory, and insights on a cautious approach ...

Research and development expenses were $21.8 million for the quarter ended December 31, 2024, compared to $11.6 million for ...